Firma Bayerische Patentallianz, Autor bei PR-Web

BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA

Posted on 15. July 2019 by Firma Bayerische Patentallianz Posted in Research / Development Tagged attack, baypat, bone, cardiac, cells, clinical, csf, ct2, dpp, dutogliptin, patients, recardio, stemi, stent, with

BayPAT, a service provider offering services in the area of technology transfer, IP management and commercialisation, today announced that its licensee Recardio is already in the Phase 2 study for regenerative therapy in early recovery post-myocardial infarction in Europe and […]

BayPAT’s Licensee Scintomics signed Sub-License Agreement with Blue Earth Diagnostics to bring rhPSMA for Prostate Cancer to Market

Posted on 7. May 201825. June 2019 by Firma Bayerische Patentallianz Posted in Research / Development Tagged baypat, cancer, cells, clinical, patients, pet, production, psa, psma, radiohybrid, rhpsma, scintomics, tracer, tum, with

BayPAT, service provider offering services in the area of technology transfer, IP management and commercialization, today announced that its licensee Scintomics has signed a sub-license and option agreement with Blue Earth Diagnostics, Ltd. In July 2017, BayPAT has out-licensed the […]

BayPAT out-licenses three novel radioligands to Scintomics

Posted on 11. December 201725. June 2019 by Firma Bayerische Patentallianz Posted in Research / Development Tagged baypat, cancer, clinical, cxcr4, filling, monozygotic, new, nugget, pet, production, psma, radiohybrid, scintomics, tracer, with

BayPAT, service provider offering services in the area of technology transfer, IP management and commercialization, today announced that Scintomics and BayPAT have entered a triple deal, comprising three license agreements in the field of radiopharmaceuticals. The novel radioligands, also called […]

Three BayPAT partner universities among the top 12 most innovative universities in Europe

Posted on 14. September 201725. June 2019 by Firma Bayerische Patentallianz Posted in Research / Development Tagged analytics, any, applications, baypat, clarivate, industry, inventions, management, research, reuters, services, technology, thomson, university, with

BayPAT, service provider offering services in the area of technology transfer, IP management and commercialization, today announced that three of its partner universities are among the most innovative universities in Europe. For the second consecutive year, Thomson Reuters, together with […]